Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
10 mM dNTP Mixture for PCR and LNP Assays
2026-09-15
Use an equimolar nucleotide stock to standardize PCR, qPCR, template preparation, and DNA sequencing workflows without adding another source of reagent variability. The same discipline is valuable in LNP delivery studies, where consistent nucleic acid preparation helps separate vector effects from cell-state and endosomal-processing effects.
-
D-Luciferin Potassium Salt for Bioluminescence Imaging
2026-09-14
D-Luciferin potassium salt is a water-soluble firefly luciferase substrate for in vivo bioluminescence imaging, luciferase reporter assays, and ATP assay workflows. Its product specifications support aqueous preparation, while the cited antimony study shows how luciferase-based imaging could complement, but not replace, mechanistic analysis of bladder cancer progression.
-
FXR–KLF11 Signaling in Contrast-Induced Kidney Injury
2026-09-14
The reference study identifies an FXR–KLF11 transcriptional pathway that limits contrast-induced acute kidney injury by suppressing JAK2/STAT3 signaling. Using CDCA, cell models, RNA sequencing, promoter assays, and genetic loss-of-function experiments, the authors connect nuclear receptor signaling with renal tubular inflammation and apoptosis while highlighting important preclinical limitations.
-
BHQ for SERCA Inhibition and Calcium Signaling
2026-09-13
BHQ provides a practical chemical entry point for testing how SERCA-dependent calcium storage influences ER stress, HSC mobilization, and vascular cell behavior. This workflow combines acute calcium assays with CXCR4, signaling, and colony-forming readouts to separate mechanism from nonspecific toxicity.
-
GSK2606414: Practical PERK Inhibition in Cell Assays
2026-09-12
Learn how GSK2606414, SKU A3448, can improve mechanistic interpretation of viability, proliferation, and cytotoxicity assays involving ER stress. This scenario-based guide covers experimental design, dosing, solvent handling, data interpretation, and practical supplier selection.
-
LNP Surface Charge and V-ATPase Shape Delivery
2026-09-11
The reference study identifies a target-cell mechanism that works with LNP surface charge to determine functional nucleic acid delivery in vitro and in vivo. Its results show that V-ATPase activity, nutritional state, reticuloendothelial conditioning, and protein-corona composition can help explain why neutral and positively charged LNPs display different tissue tropism.
-
TMB for P. vivax Epitope Serology
2026-09-11
TMB converts HRP-linked antibody binding into a practical colorimetric readout for peptide ELISA, making it useful for discovering serological markers of hidden Plasmodium vivax infection. This workflow also shows where TMB complements, rather than replaces, multiplex validation and tissue-based peroxidase assays.
-
BKT140: A CXCR4 Assay Decision Framework
2026-09-10
BKT140, also known as BL-8040, enables an endpoint-driven approach to CXCR4 research spanning chemotaxis, tumor biology, apoptosis, and stem cell mobilization. This guide connects receptor mechanism with assay selection, controls, interpretation, and translational limitations.
-
EZ Cap™ Human PTEN mRNA: Assay Design
2026-09-10
Explore how EZ Cap™ Human PTEN mRNA (ψUTP), an in vitro transcribed mRNA, can support interpretable PTEN-restoration experiments. This guide focuses on causal assay design, pathway readouts, nanoparticle benchmarking, and limitations rather than a basic handling workflow.
-
Intranasal Epinephrine in Dogs: PK and Heart Rate
2026-09-09
The reference study evaluates intranasal epinephrine as an alternative to autoinjector-based intramuscular delivery in dogs, combining pharmacokinetic measurements with heart-rate monitoring. Its key finding is that a 5 mg intranasal dose produced a faster early plasma increase and a smaller heart-rate response than a 0.3 mg intramuscular dose, while overall exposure measures were not significantly different.
-
ERADECs: ERAD-Based Degradation of TM Proteins
2026-09-09
Song et al. establish ERAD-engaging chimeras (ERADECs), a small-molecule platform that redirects the ER-associated degradation pathway toward transmembrane proteins. By using desonide to engage the ER E3 ligase SYVN1, the study achieves highly effective PD-L1 degradation, tumor suppression in vivo, and an initial extension to mutant huntingtin protein degradation.
-
FDA Drug Repurposing Identifies MERS-CoV Inhibitors
2026-09-08
de Wilde and colleagues demonstrated that screening an FDA-approved compound library can rapidly identify small molecules that suppress MERS-CoV replication in cell culture. The study positioned Lopinavir (ABT-378) among four repurposing candidates while also showing why cell-based activity requires mechanistic, pharmacokinetic, and in vivo validation before therapeutic conclusions can be drawn.
-
Metformin and AMPK in Vocal Fold Fibrosis
2026-09-08
A 2025 study reports that metformin reduced collagen accumulation and myofibroblast-associated markers in rabbit vocal fold injury and TGF-β1-stimulated fibroblasts. Its central contribution is linking this antifibrotic effect to AMPK activation, while also identifying important translational limits before clinical application.
-
CLEC5A, ISG20, and Causal Atherosclerosis Biology
2026-09-07
Zhang et al. integrated GEO transcriptomics, eQTL evidence, Mendelian randomization, and experimental models to investigate causal gene relationships in atherosclerosis. The study identifies CLEC5A and ISG20 as risk-associated genes and provides complementary evidence that ISG20 is elevated in macrophage- and endothelial-rich plaque environments.
-
BCA Protein Quantification Kit: K4102 Guide
2026-09-07
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 supports total-protein measurement in dilute samples, including many detergent-containing biochemical preparations and cell lysates. It is intended for scientific research and sample normalization, not diagnostic, clinical, or medical testing.